Conducting clinical trials is always a challenge. From protocol development to patient recruitment, the gathering of accurate and reliable data, and the regulatory oversight, trials are a lengthy and expensive process.
Then along came COVID-19. When the pandemic hit the U.S. in March 2020, many hospitals, clinics, and sponsor companies were caught by surprise. The effort to protect patients and keep them away from clinics put many trials in jeopardy. Amidst the chaos, sponsors and regulators were able to scramble and keep many trials going while considering the safety and needs of participants.
In this collection of articles from Clinical Leader, learn how companies not only survived, but created new policies that will be tomorrow’s best practices.